Top compounds associated with response to TMEM141


Feature Type Standardized
Nominal ANOVA
mRNA betulinic acid CTRPv2 pan-cancer AAC 0.058 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.054 0.2
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.048 0.2
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.054 0.2
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.051 0.2
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA CR-1-31B CTRPv2 pan-cancer AAC -0.047 0.2
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.078 0.2
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.053 0.2
Download CSV